BRCA2 hereditary breast cancer pathophenotype

Joseph N. Marcus, Patrice Watson, David L. Page, Steven A. Narod, Patricia Tonin, Gilbert M. Lenoir, Olga Serova, Henry T. Lynch

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Four BRCA2 hereditary breast cancer (HBC) families manifested significant excesses of 'tubular-lobular group' (TLG) invasive carcinomas and lobular carcinoma in situ/atypical lobular hyperplasia in comparison to BRCA1-HBC cases.

Original languageEnglish
Pages (from-to)275-277
Number of pages3
JournalBreast Cancer Research and Treatment
Volume44
Issue number3
DOIs
StatePublished - 1997

Fingerprint

Breast Neoplasms
Hyperplasia
Carcinoma
Breast Carcinoma In Situ

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Tonin, P., Lenoir, G. M., ... Lynch, H. T. (1997). BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Research and Treatment, 44(3), 275-277. https://doi.org/10.1023/A:1005830230664

BRCA2 hereditary breast cancer pathophenotype. / Marcus, Joseph N.; Watson, Patrice; Page, David L.; Narod, Steven A.; Tonin, Patricia; Lenoir, Gilbert M.; Serova, Olga; Lynch, Henry T.

In: Breast Cancer Research and Treatment, Vol. 44, No. 3, 1997, p. 275-277.

Research output: Contribution to journalArticle

Marcus, JN, Watson, P, Page, DL, Narod, SA, Tonin, P, Lenoir, GM, Serova, O & Lynch, HT 1997, 'BRCA2 hereditary breast cancer pathophenotype', Breast Cancer Research and Treatment, vol. 44, no. 3, pp. 275-277. https://doi.org/10.1023/A:1005830230664
Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Lenoir GM et al. BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Research and Treatment. 1997;44(3):275-277. https://doi.org/10.1023/A:1005830230664
Marcus, Joseph N. ; Watson, Patrice ; Page, David L. ; Narod, Steven A. ; Tonin, Patricia ; Lenoir, Gilbert M. ; Serova, Olga ; Lynch, Henry T. / BRCA2 hereditary breast cancer pathophenotype. In: Breast Cancer Research and Treatment. 1997 ; Vol. 44, No. 3. pp. 275-277.
@article{f5fcb93fcf2a42a3a82c05a67eb99a83,
title = "BRCA2 hereditary breast cancer pathophenotype",
abstract = "Four BRCA2 hereditary breast cancer (HBC) families manifested significant excesses of 'tubular-lobular group' (TLG) invasive carcinomas and lobular carcinoma in situ/atypical lobular hyperplasia in comparison to BRCA1-HBC cases.",
author = "Marcus, {Joseph N.} and Patrice Watson and Page, {David L.} and Narod, {Steven A.} and Patricia Tonin and Lenoir, {Gilbert M.} and Olga Serova and Lynch, {Henry T.}",
year = "1997",
doi = "10.1023/A:1005830230664",
language = "English",
volume = "44",
pages = "275--277",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - BRCA2 hereditary breast cancer pathophenotype

AU - Marcus, Joseph N.

AU - Watson, Patrice

AU - Page, David L.

AU - Narod, Steven A.

AU - Tonin, Patricia

AU - Lenoir, Gilbert M.

AU - Serova, Olga

AU - Lynch, Henry T.

PY - 1997

Y1 - 1997

N2 - Four BRCA2 hereditary breast cancer (HBC) families manifested significant excesses of 'tubular-lobular group' (TLG) invasive carcinomas and lobular carcinoma in situ/atypical lobular hyperplasia in comparison to BRCA1-HBC cases.

AB - Four BRCA2 hereditary breast cancer (HBC) families manifested significant excesses of 'tubular-lobular group' (TLG) invasive carcinomas and lobular carcinoma in situ/atypical lobular hyperplasia in comparison to BRCA1-HBC cases.

UR - http://www.scopus.com/inward/record.url?scp=0030789568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030789568&partnerID=8YFLogxK

U2 - 10.1023/A:1005830230664

DO - 10.1023/A:1005830230664

M3 - Article

VL - 44

SP - 275

EP - 277

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -